Φορτώνει......
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
BACKGROUND: Cough and sputum are troublesome symptoms in chronic obstructive pulmonary disease (COPD) and are associated with adverse outcomes. The efficacy of aclidinium bromide 400 µg twice daily in patients with stable COPD has been established in two phase III studies (ACCORD COPD I and ATTAIN)...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | BMJ Open Respir Res |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BMJ Publishing Group
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5174811/ https://ncbi.nlm.nih.gov/pubmed/28074135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjresp-2016-000148 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|